Seagen Inc.
ANTI-AVB6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

Last updated:

Abstract:

Provided are novel anti-.alpha.v.beta.6 antibodies and antibody-drug conjugates and methods of using such anti-.alpha.v.beta.6 antibodies and antibody-drug conjugates to treat cancer.

Status:
Application
Type:

Utility

Filling date:

4 Dec 2020

Issue date:

1 Jul 2021